Molecular Genetic Analysis of the Ryanodine Receptor Gene (RYR1) in Korean Malignant Hyperthermia Families
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Background : Malignant hyperthermia (MH) is genetically heterogeneous, with mutations in the gene encoding the skeletal muscle ryanodine receptor (RYR1) at 19q13.1 accounting for up to 80% of the cases. However, the search for known and novel mutations in the RYR1 gene is hampered by the fact that the gene contains 106 exons. We aimed to analyze mutations from the entire RYR1 coding region in Korean MH families. Methods : We investigated seven affected MH individuals and their family members. The entire RYR1 coding region from the genomic DNA was sequenced, and RYR1 haplotyping and mutational analysis were carried out. Results : We identified nine different RYR1 mutations or variations from seven Korean MH families. Among these, five previously reported mutations (p.Gly248Arg, p.Arg2435His, p.Arg2458His, p.Arg-2676Trp, and p.Leu4838Val) and four novel variations of unknown significance (p.Arg2508Cys, p.Met-4022Val, p.Glu2669Lys, and p.Ala4295Val) were identified. In two families, two variations (R2676W &M4022V, R2435H & A4295V, respectively) were identified simultaneously. Four of the observed nine mutations or variations were located outside the hotspot region of RYR1 mutations. Conclusions : These data indicate that RYR1 is a main candidate gene in Korean MH families, and that comprehensive screening of the entire coding sequence of the RYR1 gene is necessary for molecular genetic investigations in MH-susceptible individuals, owing to the presence of RYR1mutations or variations outside of the hotspot region. (Korean J Lab Med 2010;30:702-10)
Abstract
Background : Malignant hyperthermia (MH) is genetically heterogeneous, with mutations in the gene encoding the skeletal muscle ryanodine receptor (RYR1) at 19q13.1 accounting for up to 80% of the cases. However, the search for known and novel mutations in the RYR1 gene is hampered by the fact that the gene contains 106 exons. We aimed to analyze mutations from the entire RYR1 coding region in Korean MH families. Methods : We investigated seven affected MH individuals and their family members. The entire RYR1 coding region from the genomic DNA was sequenced, and RYR1 haplotyping and mutational analysis were carried out. Results : We identified nine different RYR1 mutations or variations from seven Korean MH families. Among these, five previously reported mutations (p.Gly248Arg, p.Arg2435His, p.Arg2458His, p.Arg-2676Trp, and p.Leu4838Val) and four novel variations of unknown significance (p.Arg2508Cys, p.Met-4022Val, p.Glu2669Lys, and p.Ala4295Val) were identified. In two families, two variations (R2676W &M4022V, R2435H & A4295V, respectively) were identified simultaneously. Four of the observed nine mutations or variations were located outside the hotspot region of RYR1 mutations. Conclusions : These data indicate that RYR1 is a main candidate gene in Korean MH families, and that comprehensive screening of the entire coding sequence of the RYR1 gene is necessary for molecular genetic investigations in MH-susceptible individuals, owing to the presence of RYR1mutations or variations outside of the hotspot region. (Korean J Lab Med 2010;30:702-10)
참고문헌 (35)
- Jurkat-Rott K, "Genetics and pathogenesis of malignant hyperthermia", Muscle Nerve, 23, pp.4~17 (2000)
- during a malignant hyperthermia episode in swine, "Muscle Nerve", 1988, 82~88
- Allen GC, "The sensitivity and specificity of the caffeine-halothane contracture test: a report from the North American Malignant Hyperthermia Registry. The North American Malignant Hyperthermia Registry of MHAUS", Anesthesiology, 88, pp.579~588 (1998)
- Ording H, "In vitro contracture test for diagnosis of malignant hyperthermia following the protocol of the European MH Group: results of testing patients surviving fulminant MH and unrelated low-risk subjects. The European Malignant Hyperthermia Group", Acta Anaesthesiol Scand, 41, pp.955~966 (1997)
- MacLennan DH, "Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia", Nature, 343, pp.559~561 (1990)
- Schwemmle S, "Multipoint mapping of the central core disease locus", Genomics, 17, pp.205~207 (1993)
- Quane KA, "Mutations in the ryanodine receptor gene in central core disease and malignant hyperthermia", Nat Genet, 5, pp.51~55 (1993)
- Gillard EF, "Polymorphisms and deduced amino acid substitutions in the coding sequence of the ryanodine receptor (RYR1) gene in individuals with malignant hyperthermia", Genomics, 13, pp.1247~1254 (1992)
- Zhang Y, "A mutation in the human ryanodine receptor gene associated with central core disease", Nat Genet, 5, pp.46~50 (1993)
- Levitt RC, "Evidence for the localization of a malignant hyperthermia susceptibility locus (MHS2) to human chromosome 17q", Genomics, 14, pp.562~566 (1992)
- Iles DE, "Localization of the gene encoding the alpha 2", delta-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in malignant hyperthermia susceptible families, 1994, pp.3, 969~975
- Sudbrak R, "Mapping of a further malignant hyperthermia susceptibility locus to chromosome 3q13.1", Am J Hum Genet, 56, pp.684~691 (1995)
- Gregg RG, "Assignment of the human gene for the alpha 1 subunit of the skeletal muscle DHP-sensitive Ca2+ channel (CACNL1A3) to chromosome 1q31-q32", Genomics, 15, pp.107~112 (1993)
- Robinson RL, "Multiple interacting gene products may influence susceptibility to malignant hyperthermia", Ann Hum Genet, 64, pp.307~320 (2000)
- Robinson RL, "A genome wide search for susceptibility loci in three European malignant hyperthermia pedigrees", Hum Mol Genet, 6, pp.953~961 (1997)
- Brini M, "Ryanodine receptor defects in muscle genetic diseases", Biochem Biophys Res Commun, 322, pp.1245~1255 (2004)
- Benkusky NA, "Ryanodine receptor channelopathies", Biochem Biophys Res Commun, 322, pp.1280~1285 (2004)
- Hamilton SL, "Ryanodine receptors", Cell Calcium, 38, pp.253~260 (2005)
- Ogawa Y, "Ryanodine receptor isoforms in excitation-contraction coupling", Adv Biophys, 36, pp.27~64 (1999)
- Phillips MS, "The structural organization of the human skeletal muscle ryanodine receptor (RYR1) gene", Genomics, 34, pp.24~41 (1996)
- McCarthy TV, "Ryanodine receptor mutations in malignant hyperthermia and central core disease", Hum Mutat, 15, pp.410~417 (2000)
- Ibarra MC, "Malignant hyperthermia in Japan: mutation screening of the entire ryanodine receptor type 1 gene coding region by direct sequencing", Anesthesiology, 104, pp.1146~1154 (2006)
- Brandom BW, "Genetics of malignant hyperthermia", Scientific World Journal, 6, pp.1722~1730 (2006)
- Urwyler A, "Guidelines for molecular genetic detection of susceptibility to malignant hyperthermia", Br J Anaesth, 86, pp.283~287 (2001)
- Sei Y, "Malignant hyperthermia genetic testing in North America Working Group Meeting", Anesthesiology, 100, pp.464~465 (2004)
- 김동찬, "한국인 악성고열증 환자에서 발견된 Ryanodine 수용체(RYR1) G7304A (Arg2435His) 유전자 변이와 가계 구성원의 유전자 변이 추적조사", Korean Journal of Anesthesiology, 44(1), pp.56~64 (2003), 대한마취과학회
- Sambuughin N, "North American malignant hyperthermia population:screening of the ryanodine receptor gene and identification of novelmutations", Anesthesiology, 95, pp.594~599 (2001)
- Sambuughin N, "Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population", Anesthesiology, 102, pp.515~521 (2005)
- Kraev N, "Protocol for the sequence analysis of ryanodine receptor subtype 1 gene transcripts from human leukocytes", Anesthesiology, 99, pp.289~296 (2003)
- Treves S, "Ryanodine receptor 1 mutations, dysregulation of calcium homeostasis and neuromuscular disorders", Neuromuscul Disord, 15, pp.577~587 (2005)
- Guis S, "Multiminicore disease in a family susceptible to malignant hyperthermia: histology, in vitro contracture tests, and genetic characterization", Arch Neurol, 61, pp.106~113 (2004)
- Manning BM, "Identification of novel mutations in the ryanodinereceptor gene (RYR1) in malignant hyperthermia: genotype-phenotype correlation", Am J Hum Genet, 62, pp.599~609 (1998)
- Oyamada H, "Novel mutations in C-terminal channel region of the ryanodine receptor in malignant hyperthermia patients", Jpn J Pharmacol, 88, pp.159~166 (2002)
- Tong J, "Caffeine and halothane sensitivity of intracellular Ca2+ release is altered by 15 calcium release channel (ryanodine receptor) mutations associated with malignant hyperthermia and", orcentral core disease, 1997, pp.272, 26332~26339
- Collins JS, "Detecting polymorphisms and mutations in candidate genes", Am J Hum Genet, 71, pp.1251~1252 (2002)